Having regard to the particular characteristics of these homeopathic medicinal products, such as the very low level of active principles they contain and the difficulty of applying to them the conventional statistical methods relating to clinical trials, it is desirable to provide a special, simplified registration procedure for those homeopathic medicinal products which are placed on the market without therapeutic indications in a pharmaceutical form and dosage which do not present a risk for the patient.
Recital 21, Directive (EU) 2001/83
Judgment of the Court (Eighth Chamber) of 23 April 2020. Deutsche Homöopathie-Union (DHU) Arzneimittel GmbH & Co. KG v Bundesrepublik DeutscDecision
Recitals 2, 5, 17, 21, 23, 25 and 40 of Directive 2001/83 are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … Such hindrances …
23 Apr 2020 · 62019CJ0101
Opinion of Advocate General Szpunar delivered on 18 December 2025. FARMAKEIO YZ & SIA O.E. v Ypourgos Anaptyxis kai Ependyseon and Ypourgos Decision
It should be noted that Title VIIa of Directive 2001/83, which includes, inter alia, Article 85c, was introduced by Directive 2011/62 with a view, as stated in recital 21 thereof, to addressing an ‘important threat to public health’ …
18 Dec 2025 · 62024CC0604